We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$466M
2
NVDA icon
NVIDIA
NVDA
+$435M
3
INTC icon
Intel
INTC
+$426M
4
PXD
Pioneer Natural Resource Co.
PXD
+$389M
5
MRK icon
Merck
MRK
+$354M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.64%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MUB icon
3351
iShares National Muni Bond ETF
MUB
$45.5B
– –
-4,276
Closed -$461K
MURA
3352
DELISTED
Mural Oncology
MURA
– –
-161,917
Closed -$792K
NDLS icon
3353
Noodles & Co
NDLS
$108M
– –
-36,984
Closed -$565K
NVCT icon
3354
Nuvectis Pharma
NVCT
$618M
– –
-11,883
Closed -$97.4K
OM icon
3355
Outset Medical
OM
$89.7M
– –
-10,352
Closed -$345K
OPI
3356
DELISTED
Office Properties Income Trust
OPI
– –
-36,023
Closed -$73.5K
OPTN
3357
DELISTED
OptiNose
OPTN
– –
-7,479
Closed -$164K
ORGN
3358
DELISTED
Origin Materials
ORGN
– –
-9,393
Closed -$144K
PDSB icon
3359
PDS Biotechnology
PDSB
$42.4M
– –
-110,296
Closed -$437K
PETS icon
3360
PetMed Express
PETS
$42.5M
– –
-45,818
Closed -$219K
PLX icon
3361
Protalix BioTherapeutics
PLX
$197M
– –
-271,795
Closed -$342K
PMVP icon
3362
PMV Pharmaceuticals
PMVP
$64M
– –
-152,959
Closed -$260K
PRTS icon
3363
CarParts.com
PRTS
$54.2M
– –
-172,423
Closed -$2.79M
PWOD
3364
DELISTED
Penns Woods Bancorp
PWOD
– –
-10,338
Closed -$201K
RIGL icon
3365
Rigel Pharmaceuticals
RIGL
$754M
– –
-322,335
Closed -$4.77M
RLYB icon
3366
Rallybio
RLYB
$85.3M
– –
-7,981
Closed -$118K
RRGB icon
3367
Red Robin
RRGB
$155M
– –
-31,374
Closed -$240K
SEER icon
3368
Seer Inc
SEER
$119M
– –
-179,279
Closed -$341K
SGMO
3369
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-737,464
Closed -$494K
SGMT icon
3370
Sagimet Biosciences
SGMT
$545M
– –
-91,655
Closed -$497K
SHV icon
3371
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
– –
-24,434
Closed -$2.7M
SKIL icon
3372
Skillsoft
SKIL
$82.7M
– –
-86,745
Closed -$781K
SKYX icon
3373
SKYX Platforms
SKYX
$164M
– –
-84,826
Closed -$111K
SMTI icon
3374
Sanara MedTech
SMTI
$313M
– –
-5,537
Closed -$205K
SNFCA icon
3375
Security National Financial
SNFCA
$249M
– –
-17,406
Closed -$119K
133 134
135
136 137

Similar funds

Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.